CD44 and prostate cancer: Interestingly, prostate cancer cells with low AR expression have higher expression of the stem cell marker CD44, and knocking down menin in prostate cancer cells similarly leads to increased expression of CD44 [307], suggesting that menin may promote the dedifferentiation of prostate cancer cells by decreasing AR expression.